Leupin W, Feigon J, Denny W A, Kearns D R
Biophys Chem. 1985 Oct;22(4):299-305. doi: 10.1016/0301-4622(85)80053-3.
The binding of eight ethidium derivatives to short (approximately 35 base-pair), random sequence DNA has been investigated using 1H-NMR. At 35 degrees C, all drugs cause upfield shifts of the DNA imino proton resonances characteristic of intercalative binding to DNA, but the line shapes vary significantly with the nature of the drug. The results confirm our previous proposal that removal of the amino group at position-3, but not at position-8, on the parent ethidium shortens the lifetime of the intercalative state (less than 1-2 ms at 35 degrees C). These results suggest that hydrogen-bonding interactions with the 3-NH2 group are involved in stabilization of the drug-DNA complex or that changes in charge distribution that accompany removal of the 3-NH2 group reduce the complex stability. The magnitude of the shift of the drug-DNA spectra indicates a slight preference for binding of the drugs adjacent to G X C base-pairs.
利用核磁共振氢谱(1H-NMR)研究了八种乙锭衍生物与短链(约35个碱基对)随机序列DNA的结合情况。在35℃时,所有药物都会使DNA亚氨基质子共振发生向上位移,这是插入结合到DNA的特征,但谱线形状会因药物性质的不同而有显著差异。结果证实了我们之前的推测,即母体乙锭上3位而非8位的氨基去除会缩短插入态的寿命(在35℃时小于1 - 2毫秒)。这些结果表明,与3 - NH₂基团的氢键相互作用参与了药物 - DNA复合物的稳定,或者说去除3 - NH₂基团伴随的电荷分布变化降低了复合物的稳定性。药物 - DNA光谱的位移幅度表明,这些药物略微倾向于结合在G×C碱基对附近。